-
If you purchased shares of Amedisys Inc (NASDAQ: AMED), you might have certain options and should contact the Shareholders Foundation, Inc.
-
To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Lawsuit Overview
December 20, 2017 - The court approved the settlement and entered the orders approving the plan of allocation, the motion for attorneys’ fees and expenses, and dismissing the action with prejudice. August 21, 2017 - The court preliminarily approved the settlement. August 4, 2017 - Parties filed a stipulation of settlement. August 19, 2016 - The court granted in part and denied in ...
You must register (for free) or login to view the entire case.
